A Revolution in prostate biopsy
The Forsvall Biopsy Needle (above) vs. the standard Tru-Cut needle (below):
- Built to travel straight in tissue to significantly improve precision
- The patented needle design reduces bacterial transfer by 96% vs Tru-Cut needle* (bacteria collected between needle parts - se arrow)
- Based on years of R&D – it is both no different in clinical workflow from currently available instruments – yet revolutionary in practice
- FDA 510(k) and ISO 13485
Clinical value
Comments about the Forsvall Biopsy System
Unique features
*PMID: 33999753
**PMID: 33999764
***A.Forsvall, M. Utter, M. Wagenius, A0758 – Precision in targeted prostate biopsy: A comparative in-vitro study of a novel needle design vs. Tru-Cut needle, European Urology, Volume 87, Supplement 2, 2025, Page S1595, ISSN 0302-2838,
https://doi.org/10.1016/j.eururo.2025.09.3944
The Science
Xaga Surgical´s primary goal has been to transition from identifying problems to delivering effective solutions, which has culminated in our first breakthrough development - the Forsvall Biopsy System. The scientific foundation underpinning these advancements are being explored further with several new products in development.
~4 million prostate biopsies globally per year
~1 million prostate biopsies in the US per year
Certificates & Awards
U.S. FDA 510(k)
Clearance for the Forsvall Biopsy Needle System (K242128) registration for use in the U.S.
ISO 13485:2016
Ensuring the highest standards of quality and safety in medical devices
Best paper
By Engineering & Urology Society, AUA Annual Meeting 2025, Las Vegas
Top ten most promising global startups
In urology by AUA | Innovation Nexus, AUA Annual Meeting 2024, San Antonio
Best abstract
By International Prostate Cancer Update 2023, Vail, Colorado

